Zimmer Biomet Holdings, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US98956P1021
USD
99.49
-1.5 (-1.49%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
2,243.80
2,001.40
2,077.30
1,909.10
2,023.20
1,824.20
1,942.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,243.80
2,001.40
2,077.30
1,909.10
2,023.20
1,824.20
1,942.00
Raw Material Cost
982.10
746.50
767.00
719.90
762.00
700.10
719.30
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
71.00
73.80
75.80
63.30
59.20
51.30
50.90
Selling and Distribution Expenses
860.00
808.30
809.50
756.70
719.50
705.90
733.70
Other Expenses
4.78
4.21
3.75
4.73
4.92
6.03
5.85
Total Expenditure (Excl Depreciation)
1,960.90
1,670.70
1,689.80
1,587.20
1,589.90
1,517.60
1,562.40
Operating Profit (PBDIT) excl Other Income
282.9
330.7
387.5
321.9
433.29999999999995
306.6
379.6
Other Income
19.50
4.50
28.20
26.30
-17.60
36.60
10.60
Operating Profit (PBDIT)
586.40
618.80
687.50
602.60
679.30
594.10
633.40
Interest
71.00
73.80
75.80
63.30
59.20
51.30
50.90
Exceptional Items
-133.50
17.80
-115.30
-55.90
-67.50
-61.60
-37.20
Gross Profit (PBDT)
1,261.70
1,254.90
1,310.30
1,189.20
1,261.20
1,124.10
1,222.70
Depreciation
284.00
283.60
271.80
254.40
263.60
250.90
243.20
Profit Before Tax
98.00
279.20
224.60
229.00
289.00
230.30
302.20
Tax
-39.90
48.00
71.20
46.50
49.00
-18.90
59.10
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
139.40
230.90
152.80
182.00
239.40
249.00
242.80
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
139.40
230.90
152.80
182.00
239.40
249.00
242.80
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.50
0.30
0.60
0.60
0.60
0.20
0.30
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
137.90
231.20
153.40
182.60
240.00
249.20
243.10
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
12,697.70
12,756.50
12,525.00
12,395.10
12,468.10
12,374.70
12,741.10
Earnings per share (EPS)
0.7
1.16
0.77
0.91
1.2
1.23
1.18
Diluted Earnings per share
0.7
1.16
0.77
0.91
1.2
1.23
1.18
Operating Profit Margin (Excl OI)
12.61%
16.52%
18.65%
16.86%
21.42%
16.81%
19.55%
Gross Profit Margin
17.02%
28.12%
23.9%
25.32%
27.31%
26.38%
28.08%
PAT Margin
6.21%
11.54%
7.36%
9.53%
11.83%
13.65%
12.5%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 10.90% vs 4.28% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is -42.54% vs -42.80% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is -18.65% vs 6.09% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is 19.93% vs 24.37% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024

Compare Quarterly Results Of Zimmer Biomet Holdings, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
2,243.80
1,129.73
1,114.07
98.61%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,243.80
1,129.73
1,114.07
98.61%
Raw Material Cost
982.10
473.97
508.13
107.21%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
71.00
19.29
51.71
268.07%
Selling and Distribution Expenses
860.00
259.83
600.17
230.99%
Other Expenses
4.78
3.33
1.45
43.54%
Total Expenditure (Excl Depreciation)
1,960.90
786.40
1,174.50
149.35%
Operating Profit (PBDIT) excl Other Income
282.90
343.34
-60.44
-17.60%
Other Income
19.50
11.31
8.19
72.41%
Operating Profit (PBDIT)
586.40
387.41
198.99
51.36%
Interest
71.00
19.29
51.71
268.07%
Exceptional Items
-133.50
-6.29
-127.21
-2,022.42%
Gross Profit (PBDT)
1,261.70
655.76
605.94
92.40%
Depreciation
284.00
32.77
251.23
766.65%
Profit Before Tax
98.00
329.07
-231.07
-70.22%
Tax
-39.90
43.31
-83.21
-192.13%
Provisions and contingencies
0
0
0.00
Profit After Tax
139.40
285.76
-146.36
-51.22%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
139.40
285.76
-146.36
-51.22%
Share in Profit of Associates
0
0
0.00
Minority Interest
-1.50
0.00
-1.50
Other related items
0.00
0.00
0.00
Consolidated Net Profit
137.90
285.76
-147.86
-51.74%
Equity Capital
0
0
0.00
Face Value
0.01
0.01
0.00
Reserves
12,697.70
-23.64
12,721.34
53,812.77%
Earnings per share (EPS)
0.70
13.98
-13.28
-94.99%
Diluted Earnings per share
0.70
13.98
-13.28
-94.99%
Operating Profit Margin (Excl OI)
12.61%
30.39%
0.00
-17.78%
Gross Profit Margin
17.02%
32.03%
0.00
-15.01%
PAT Margin
6.21%
25.29%
0.00
-19.08%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 224.38 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 12.11% vs -3.65% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 10.90% vs 4.28% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 13.79 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -40.35% vs 50.72% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -42.54% vs -42.80% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 56.69 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -7.72% vs -6.83% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -18.65% vs 6.09% in Dec 2024

Quarterly - Interest
Interest 7.10 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -3.79% vs -2.64% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 19.93% vs 24.37% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.61%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024